Fresenius Medical Care AG... (FMS)
24.56
-0.07 (-0.28%)
At close: Jan 28, 2025, 1:50 PM
Fresenius Medical Care AG & Co. KGaA Revenue Breakdown
| Quarter | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|
| Health Care Products Revenue | 9.18M | 14.92M |
| Health Care Products Revenue Growth | -38.44% | n/a |
| Health Care Services Revenue | 3.83B | 3.71B |
| Health Care Services Revenue Growth | +3.12% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2013 | Dec 31, 2011 |
|---|---|---|---|---|---|---|
| Germany Revenue | 487.28M | 511.39M | 421.60M | 400.40M | 437.46M | 425.51M |
| Germany Revenue Growth | -4.71% | +21.30% | +5.30% | -8.47% | +2.81% | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Apr 6, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 756.15M | 771.47M | 776.00M | 845.00M | 793.79M | 775.24M | 782.15M | 955.00M | 989.61M | 969.49M | 871.24M | 823.00M | 731.23M | 830.18M | 711.51M | 905.00M | 717.75M | 738.00M | 854.46M | 815.00M | 724.43M | 802.53M | 715.16M | 729.00M | 742.68M | 715.18M | 692.00M | 954.00M | 801.23M | 899.54M | 923.13M | 730.25M | 701.37M | 658.21M | 669.23M | 708.86M | 659.73M | 644.27M | 604.77M |
| Selling, General, and Administrative Revenue Growth | -1.99% | -0.58% | -8.17% | +6.45% | +2.39% | -0.88% | -18.10% | -3.50% | +2.08% | +11.28% | +5.86% | +12.55% | -11.92% | +16.68% | -21.38% | +26.09% | -2.74% | -13.63% | +4.84% | +12.50% | -9.73% | +12.22% | -1.90% | -1.84% | +3.85% | +3.35% | -27.46% | +19.07% | -10.93% | -2.56% | +26.41% | +4.12% | +6.56% | -1.65% | -5.59% | +7.45% | +2.40% | +6.53% | n/a |
| Research and Development Revenue | 40.05M | 45.59M | 48.00M | 66.00M | 53.04M | 57.18M | 55.76M | 62.00M | 61.48M | 55.42M | 49.67M | 68.00M | 52.36M | 52.02M | 48.65M | 52.00M | 44.92M | 51.00M | 45.92M | 49.00M | 49.17M | 41.02M | 33.61M | 38.00M | 25.74M | 37.65M | 32.00M | 36.00M | 27.70M | 35.10M | 32.14M | 39.94M | 39.13M | 34.85M | 33.07M | 36.59M | 31.05M | 30.74M | 28.57M |
| Research and Development Revenue Growth | -12.15% | -5.03% | -27.27% | +24.43% | -7.25% | +2.55% | -10.06% | +0.84% | +10.95% | +11.57% | -26.95% | +29.87% | +0.66% | +6.93% | -6.45% | +15.75% | -11.92% | +11.07% | -6.29% | -0.35% | +19.88% | +22.03% | -11.54% | +47.62% | -31.62% | +17.65% | -11.11% | +29.99% | -21.09% | +9.21% | -19.53% | +2.06% | +12.28% | +5.39% | -9.62% | +17.83% | +1.00% | +7.61% | n/a |
| Sales and Marketing Revenue | 200.32M | n/a | 190.56M | n/a | n/a | n/a | 203.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |